Amgen News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

25.11.13	AMGN, GSK Get FDA Nod, CLDX Walks The Talk, OREX Awaits Light, CELG On A High (RTTNews)
23.11.13	FDA Approves Nexavar For Treatment Of A Type Of Thyroid Cancer (RTTNews)
20.11.13	Amgen Says Results From 52-week Study Of Evolocumab Is Encouraging (RTTNews)
22.10.13	Amgen Profit Tops Estimates; Lifts FY Guidance (RTTNews)
22.10.13	Amgen Q3 Profit Tops View; Lifts FY13 Revenue Outlook - Quick Facts (RTTNews)
22.10.13	Amgen's Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94 (PR Newswire)
22.10.13	Amgen To Buy Filgrastim Franchise Rights From Roche In 100 Markets - Quick Facts (RTTNews)
22.10.13	Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets (PR Newswire)
22.10.13	Stock Price Movements, Clinical Study Results, and New Appointments - Research Report on Pfizer, Gilead Sciences, Amgen, Celgene, and Insys Therapeutics (PR Newswire)
22.10.13	Earnings Watch For October 22 (UTX, TRV, JNPR, AMGN, KMB,DD) (RTTNews)
17.10.13	Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc. (PR Newswire)
16.10.13	Amgen Announces Appointment Of Greg C. Garland To Board Of Directors (PR Newswire)
16.10.13	Amgen Announces 2013 Fourth Quarter Dividend (PR Newswire)
09.10.13	FDA Approvals, Completed Tender Offers, Hospital Ratings, Trial Study Results, and Stock Price Movements - Research Report on Pfizer, Amgen, Cigna, Hologic, and Insys Therapeutics (PR Newswire)
04.10.13	Critical Alerts For Apple, Amgen, Charles Schwab, TJX Companies, and Mattel Released By InvestorsObserver (PR Newswire)
04.10.13	Amgen Presents Nearly Two Dozen Abstracts From Romosozumab And Prolia® (Denosumab) At ASBMR (PR Newswire)
03.10.13	Amgen, AstraZeneca To Present Key Studies Evaluating Brodaluma - Quick Facts (RTTNews)
02.10.13	Presentation on Research Findings, Recognitions, Clinical Trial Results, and Orphan Drug Designations - Research Report on Celgene, Biogen Idec, Amgen, Nektar, and Zalicus (PR Newswire)
01.10.13	License Agreements, Strategic Partnerships, Regulatory Approvals, Acquisitions and Sale of Senior Notes - Research Report on Johnson & Johnson, Amgen, Gilead, MAKO, and Edwards Lifesciences (PR Newswire)
01.10.13	Amgen Closes Onyx Pharma Tender Offer - Quick Facts (RTTNews)
01.10.13	Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer (PR Newswire)
30.09.13	Amgen Reports Addl. Results From Phase 3 Trial Of Talimogene Laherparepvec (RTTNews)
30.09.13	Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma (PR Newswire)
28.09.13	Amgen's Phase 3 Trial Comparing Vectibix To Erbitux Meets Primary Endpoint (RTTNews)
27.09.13	Updates on Pipeline Developments, Facility Expansions, and Conference Calls - Research Report on Merck, UnitedHealth, Amgen, Baxter, and Charles River (PR Newswire)
25.09.13	Amgen And ShanghaiTech University Announce Plans For Amgen China R&D Center To Open On ShanghaiTech Campus (PR Newswire)
20.09.13	Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc. (PR Newswire)
18.09.13	Amgen Annunces Termination Of HSR Waiting Period For Amgen Acquisition (RTTNews)
18.09.13	Pipeline Developments, Product Recalls, Clinical Trial Results, Recognitions, and New Appointments - Research Report on Johnson & Johnson, Amgen, Regeneron, UnitedHealth, and Bristol-Myers (PR Newswire)
16.09.13	Collaborations, New Studies, and New Drug Applications - Research Report on Amgen, Gilead, Abbott, Biogen Idec, and UnitedHealth (PR Newswire)
12.09.13	Amgen Highlights Data To Be Presented At 2013 European Cancer Congress (PR Newswire)
12.09.13	FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina (PR Newswire)
06.09.13	Amgen To Present At The Morgan Stanley Global Healthcare Conference (PR Newswire)
04.09.13	Critical Alerts For Boeing, Amgen, Fortinet, Family Dollar Stores, and Raytheon Released By InvestorsObserver (PR Newswire)
03.09.13	Pharmaceuticals Report Revolutionary Findings, Approved Treatments, Investor Conferences - Research Report on Celgene, Amgen, Biogen Idec, Regeneron, and Questcor (PR Newswire)
01.09.13	Amgen Presents Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol (RTTNews)
01.09.13	Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients (PR Newswire)
30.08.13	Amgen To Participate At Citi's 8th Annual Biotech Conference (PR Newswire)
29.08.13	ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Onyx Pharmaceuticals, Inc. (PR Newswire)
28.08.13	Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray (PR Newswire)
27.08.13	Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders (PR Newswire)
26.08.13	Pre-market Movers For Aug 26 (ONXX, AMGN, TSLA, RIGL) (RTTNews)
26.08.13	AMGN Opens Wallet For ONXX, SHIELD-1 Fails To Protect CCXI, ZMH Gets FDA Nod (RTTNews)
26.08.13	Amgen To Buy Cancer Drug Maker Onyx Pharmaceuticals For $10.4 Bln (RTTNews)
25.08.13	Amgen Reportedly Close To Buy Onyx Pharma For About $125 A Share (RTTNews)
21.08.13	Healthy Outlook for Healthcare Supported by Trial Milestones, Approvals, Partnerships, and Commercialization - Research Report on Lilly, Celgene, Onyx, Amgen, and GSK (PR Newswire)
14.08.13	Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc. (PR Newswire)
13.08.13	Amgen And Servier Complete Product Collaboration Transaction (PR Newswire)
06.08.13	Solid Margins, Financial Strategies, and Earnings Reports Support Long-Term Growth in Biotech - Research Report on Gilead Sciences, Celgene, Onyx Pharmaceuticals, Questcor, and Amgen (PR Newswire)
02.08.13	Investments in R&D Activities and Strong Product Sales Strengthen Companies' Financial Positions - Research Report on Alexion, Amgen, Vertex, Aegerion, and Acadia (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	534.60	0.68 %	K V
Novartis	92.44	0.55 %	K V
Part Grp Hldg	1’257.50	0.52 %	K V
Alcon	77.90	0.36 %	K V
Swisscom	505.50	0.30 %	K V
Swiss Life Hldg	717.20	-0.31 %	K V
UBS Group	27.57	-0.68 %	K V
ABB	49.14	-0.81 %	K V
Sika	225.90	-1.18 %	K V
Logitech Intl	70.56	-1.97 %	K V

mehr

15:58		Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer
15:58		XETRA-Handel: SDAX am Nachmittag freundlich
15:58		Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell
13:28		Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse
12:26		XETRA-Handel: SDAX zeigt sich fester
12:26		Schwacher Wochentag in Europa: So performt der Euro STOXX 50 mittags
12:26		Mittwochshandel in Frankfurt: TecDAX gibt am Mittag nach
09:28		Euro STOXX 50 aktuell: Euro STOXX 50 notiert zum Start im Minus